PubRank

John D Cleary

Author PubWeight™ 38.72‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Repeat instability: mechanisms of dynamic mutations. Nat Rev Genet 2005 5.37
2 Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint. Antimicrob Agents Chemother 2009 3.13
3 Repeat instability as the basis for human diseases and as a potential target for therapy. Nat Rev Mol Cell Biol 2010 3.09
4 A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects. Clin Infect Dis 2003 2.84
5 Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae. J Biol Chem 2003 1.94
6 CTCF cis-regulates trinucleotide repeat instability in an epigenetic manner: a novel basis for mutational hot spot determination. PLoS Genet 2008 1.72
7 Slipped-strand DNAs formed by long (CAG)*(CTG) repeats: slipped-out repeats and slip-out junctions. Nucleic Acids Res 2002 1.64
8 Implementation and refinement of a problem-based learning model: a ten-year experience. Am J Pharm Educ 2007 1.60
9 Voriconazole: a new triazole antifungal agent. Ann Pharmacother 2003 1.47
10 Delivery of antifungal agents using bioactive and nonbioactive bone cements. Ann Pharmacother 2009 1.31
11 Repeat-associated non-ATG (RAN) translation in neurological disease. Hum Mol Genet 2013 1.20
12 In vitro (CTG)*(CAG) expansions and deletions by human cell extracts. J Biol Chem 2002 1.06
13 In search of the holy grail of antifungal therapy. Trans Am Clin Climatol Assoc 2008 0.97
14 Genetic diversity of Trichomonas vaginalis clinical isolates determined by EcoRI restriction fragment length polymorphism of heat-shock protein 70 genes. Am J Trop Med Hyg 2009 0.91
15 Atypical tuberculosis skin test reaction. Ann Pharmacother 2003 0.86
16 Cardiac toxicity of some echinocandin antifungals. Expert Opin Drug Saf 2013 0.86
17 The interaction of mannose binding lectin (MBL) with mannose containing glycopeptides and the resultant potential impact on invasive fungal infection. Med Mycol 2008 0.83
18 Blue digits: cyanosis resulting from norepinephrine treatment. Ann Pharmacother 2005 0.79
19 Differential expression of genes encoding immunomodulatory proteins in response to amphotericin B in human mononuclear cells identified by cDNA microarray analysis. J Antimicrob Chemother 2002 0.79
20 Buffalo hump in an HIV-infected patient. Ann Pharmacother 2002 0.78
21 Clinical roundtable monograph: safety and efficacy of lipid-based amphotericin B. Clin Adv Hematol Oncol 2009 0.78
22 Steroid-induced avascular necrosis. Ann Pharmacother 2002 0.78
23 Medication-induced adverse effects: important concepts for the hand therapist. J Hand Ther 2010 0.77
24 The contribution of Raman scattering to the fluorescence of the polyene antibiotic amphotericin B. J Fluoresc 2010 0.76
25 Evidence that impurities contribute to the fluorescence of the polyene antibiotic amphotericin B. J Antimicrob Chemother 2009 0.75
26 T. asahii pulmonary infection as a complication of TNF-inhibitor and steroids: posaconazole pharmacotherapy and risk analysis. J Miss State Med Assoc 2011 0.75
27 Herpes simplex virus encephalitis pharmacotherapy: alternative treatment options. Ann Pharmacother 2013 0.75
28 Toll-like receptor 4 polymorphisms and aspergillosis. N Engl J Med 2009 0.75
29 Evaluation of a positive yeast-in-blood service. Am J Med Sci 2014 0.75
30 Thrombocytosis during antifungal therapy of candidemia. Ann Pharmacother 2005 0.75
31 Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt. Clin Infect Dis 2006 0.75
32 Bioavailability of promethazine in a topical pluronic lecithin organogel: a pilot study. Int J Pharm Compd 2013 0.75
33 Acyclovir-induced crystalluria. Ann Pharmacother 2002 0.75